Delivery Order SPE2DB22D2206-SPE2DB25FFF97
Award Date
1/24/25
Potential Completion Date
2/14/25
Potential Value
$2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,336.98 firm fixed-price delivery order is for the supply of ZOLADEX 10.8 MG IMPLANT SYRNS medical products. The contract has an ultimate completion date of January 21, 2025. Amerisourcebergen Drug Corp holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $3,509.16 to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the federal government. The contract is for the delivery of ZOLADEX 10.8 MG IMPLANT SYRNS, with a completion date of June 13, 2024. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00...
This federal contract award, valued at $1,873.74, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of the pharmaceutical product ZOLADEX 3.6 MG IMPLANT SYRNS, with a completion date of May 10, 2024. Amerisourcebergen, a large pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to...
This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of 4,565,606,804 units of the pharmaceutical product ZOLADEX 10.8 MG IMPLANT SYRNS. The contract has a firm fixed price ceiling value of $1,754.58 and an ultimate completion date of September 17, 2024. AmerisourceBergen, a major supplier of pharmaceutical products and medical supplies to the U.S. government, has been awarded this delivery order contract without any set-aside...
This federal contract award, valued at $1,292.36, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ZOLADEX 3.6 MG IMPLANT SYRNS, a specialty medication. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for...
This federal contract award, with an ID of SPE2DB20D3103|SPE2DB25FM3Q6, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $22,314.00 Firm Fixed Price Delivery Order contract is for the supply of ZOLADEX 10.8 MG IMPLANT SYRNS, a specialty pharmaceutical product. The contract has an ultimate completion date of February 7, 2025. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,735.50, is a Firm Fixed Price Delivery Order to provide ZOLADEX 10.8 MG IMPLANT SYRNS, a specialty pharmaceutical product. The contract has a completion date of March 4, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide ZOLADEX 10.8 MG IMPLANT SYRNS. The $2,722.83 firm fixed-price delivery order contract has an ultimate completion date of December 13, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This federal contract award, valued at $2,379.18, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the delivery of 4,565,607,277 ZOLADEX 10.8 MG IMPLANT SYRNS, a pharmaceutical product. The contract has a firm fixed price and a period of performance through September 17, 2024. AmerisourceBergen, as a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, has been awarded...
This is a federal contract award issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of ZOLADEX 3.6 MG IMPLANT SYRNS, a pharmaceutical product. The contract has a ceiling value of $3,122.90 and is a Firm Fixed Price Delivery Order. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the...